274 related articles for article (PubMed ID: 17967309)
1. Postoperative high-dose-rate brachytherapy in the prevention of keloids.
Veen RE; Kal HB
Int J Radiat Oncol Biol Phys; 2007 Nov; 69(4):1205-8. PubMed ID: 17967309
[TBL] [Abstract][Full Text] [Related]
2. Biologically effective doses of postoperative radiotherapy in the prevention of keloids. Dose-effect relationship.
Kal HB; Veen RE
Strahlenther Onkol; 2005 Nov; 181(11):717-23. PubMed ID: 16254707
[TBL] [Abstract][Full Text] [Related]
3. Postoperative strontium-90 brachytherapy in the prevention of keloids: results and prognostic factors.
Viani GA; Stefano EJ; Afonso SL; De Fendi LI
Int J Radiat Oncol Biol Phys; 2009 Apr; 73(5):1510-6. PubMed ID: 19101094
[TBL] [Abstract][Full Text] [Related]
4. Clinical comparison of two linear-quadratic model-based isoeffect fractionation schemes of high-dose-rate intracavitary brachytherapy for cervical cancer.
Wang CJ; Huang EY; Sun LM; Chen HC; Fang FM; Hsu HC; Changchien CC; Leung SW
Int J Radiat Oncol Biol Phys; 2004 May; 59(1):179-89. PubMed ID: 15093915
[TBL] [Abstract][Full Text] [Related]
5. High-dose-rate (HDR) or pulsed-dose-rate (PDR) perioperative interstitial intensity-modulated brachytherapy (IMBT) for local recurrences of previously irradiated breast or thoracic wall following breast cancer.
Niehoff P; Dietrich J; Ostertag H; Schmid A; Kohr P; Kimmig B; Kovács G
Strahlenther Onkol; 2006 Feb; 182(2):102-7. PubMed ID: 16447017
[TBL] [Abstract][Full Text] [Related]
6. Low-dose-rate brachytherapy is superior to high-dose-rate brachytherapy for bladder cancer.
Pos FJ; Horenblas S; Lebesque J; Moonen L; Schneider C; Sminia P; Bartelink H
Int J Radiat Oncol Biol Phys; 2004 Jul; 59(3):696-705. PubMed ID: 15183473
[TBL] [Abstract][Full Text] [Related]
7. [The radiotherapy of vaginal keloids by an intracavity high-dose-rate (HDR) afterloading procedure].
Busch M; Burmester U; Kuhn W; Dühmke E
Strahlenther Onkol; 1991 Jun; 167(6):358-60. PubMed ID: 2068651
[TBL] [Abstract][Full Text] [Related]
8. Prospective study of HDR (192Ir) versus MDR (137Cs) intracavitary brachytherapy for carcinoma of the uterine cervix.
Tanaka E; Oh RJ; Yamada Y; Shiomi H; Nakamura S; Shimamoto S; Teshima T; Inoue T; Inoue T
Brachytherapy; 2003; 2(2):85-90. PubMed ID: 15062145
[TBL] [Abstract][Full Text] [Related]
9. Postoperative management of keloids: low-dose-rate and high-dose-rate brachytherapy.
De Cicco L; Vischioni B; Vavassori A; Gherardi F; Jereczek-Fossa BA; Lazzari R; Cattani F; Comi S; De Lorenzi F; Martella S; Orecchia R
Brachytherapy; 2014; 13(5):508-13. PubMed ID: 24556345
[TBL] [Abstract][Full Text] [Related]
10. Dose-effect relationships for recurrence of keloid and pterygium after surgery and radiotherapy.
Kal HB; Veen RE; Jürgenliemk-Schulz IM
Int J Radiat Oncol Biol Phys; 2009 May; 74(1):245-51. PubMed ID: 19362243
[TBL] [Abstract][Full Text] [Related]
11. Is the treatment of keloid scars still a challenge in 2006?
De Lorenzi F; Tielemans HJ; van der Hulst RR; Rhemrev R; Nieman FH; Lutgens LC; Boeckx WD
Ann Plast Surg; 2007 Feb; 58(2):186-92. PubMed ID: 17245147
[TBL] [Abstract][Full Text] [Related]
12. Nerve tolerance to high-dose-rate brachytherapy in patients with soft tissue sarcoma: a retrospective study.
Kubo T; Sugita T; Shimose S; Matsuo T; Hirao K; Kimura H; Kenjo M; Ochi M
BMC Cancer; 2005 Jul; 5():79. PubMed ID: 16026629
[TBL] [Abstract][Full Text] [Related]
13. Perioperative Interstitial High-Dose-Rate Brachytherapy for the Treatment of Recurrent Keloids: Feasibility and Early Results.
Jiang P; Baumann R; Dunst J; Geenen M; Siebert FA; Niehoff P; Bertolini J; Druecke D
Int J Radiat Oncol Biol Phys; 2016 Mar; 94(3):532-6. PubMed ID: 26867882
[TBL] [Abstract][Full Text] [Related]
14. High-dose-rate (HDR) brachytherapy for the treatment of benign obstructive endobronchial granulation tissue.
Madu CN; Machuzak MS; Sterman DH; Musani A; Ahya V; McDonough J; Metz JM
Int J Radiat Oncol Biol Phys; 2006 Dec; 66(5):1450-6. PubMed ID: 16997502
[TBL] [Abstract][Full Text] [Related]
15. Results of postoperative (90)Sr radiotherapy of keloids in view of patients' subjective assessment.
Fraunholz IB; Gerstenhauer A; Böttcher HD
Strahlenther Onkol; 2005 Nov; 181(11):724-9. PubMed ID: 16254708
[TBL] [Abstract][Full Text] [Related]
16. Dose-response relationship and dose optimization in radiotherapy of postoperative keloids.
Sakamoto T; Oya N; Shibuya K; Nagata Y; Hiraoka M
Radiother Oncol; 2009 May; 91(2):271-6. PubMed ID: 19201502
[TBL] [Abstract][Full Text] [Related]
17. Keloids treated with postoperative Iridium 192* brachytherapy: a retrospective study.
Arnault JP; Peiffert D; Latarche C; Chassagne JF; Barbaud A; Schmutz JL
J Eur Acad Dermatol Venereol; 2009 Jul; 23(7):807-13. PubMed ID: 19470053
[TBL] [Abstract][Full Text] [Related]
18. Postoperative radiotherapy with high dose rate iridium 192 mould for prevention of earlobe keloids.
Narkwong L; Thirakhupt P
J Med Assoc Thai; 2006 Apr; 89(4):428-33. PubMed ID: 16696385
[TBL] [Abstract][Full Text] [Related]
19. Effect of high-dose-rate 192Ir source activity on late rectal bleeding after intracavitary radiation therapy for uterine cervix cancer.
Suzuki O; Yoshioka Y; Isohashi F; Morimoto M; Kotsuma T; Kawaguchi Y; Konishi K; Nakamura S; Shiomi H; Inoue T
Int J Radiat Oncol Biol Phys; 2008 Aug; 71(5):1329-34. PubMed ID: 18439763
[TBL] [Abstract][Full Text] [Related]
20. American Brachytherapy Society survey regarding practice patterns of postoperative irradiation for endometrial cancer: current status of vaginal brachytherapy.
Small W; Erickson B; Kwakwa F
Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1502-7. PubMed ID: 16109462
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
